Comparison of intravenous ibuprofen and intravenous ketorolac effectivity for non-specific acute musculoskeletal pain
Article Sidebar
-
Non-Specific Acute Musculoskeletal Pain, Pain Intensity, Intravenous Ibuprofen, Intravenous Ketorolac
Abstract
Acute musculoskeletal pain is an illness of muscle, bone, joint, and muscle tissue that is caused by an injury or inflammation. Ibuprofen and Ketorolac are Non-Steroid Anti-Inflammatory Drugs or NSAID that are usually used for non-specific acute musculoskeletal pain. The purpose of the study is to compare the pain relief of non-specific acute musculoskeletal pain between intravenous Ibuprofen and intravenous Ketorolac therapy. This study uses a quasi-experimental, non-randomized, non-equivalent, active comparator, open-label study. The total sample for this study is 60 subjects, divided into two groups (n-30), subjects are required by using purposive sampling. Pain measured by Numeric Pain Scale. The mean baseline of the pain intensity were 63.33 ± 8.841 for the Ibuprofen group and 59.33 ± 12.847 for the Ketorolac group. There was not any differences between both of group (p = 0.107) after the medication were given all measurement shows significant differences between two groups (p = <0.05) that Ibuprofen group shows better results. Intravenous Ibuprofen has better effectivity rather than intravenous Ketorolac as a treatment of non-specific acute musculoskeletal pain.
Full text article
References
Arendt-Nielsen, L., de-las Peñas, C. F., Graven- Nielsen, T. 2011. Basic aspects of musculoskeletal pain: from acute to chronic pain. Journal of Manual and Manipulative Therapy, 19(4):186–193.
Carr, A. C., McCall, C. 2017. The role of vitamin C in the treatment of pain: new insights. Journal of Translational Medicine, 15(1):1–14.
Gazoni, F. M., Malezan, W. R., Santos, F. C. 2016. B complex vitamins for analgesic therapy. Revista Dor, 17(1):52–56.
Helde-Frankling, M., Björkhem-Bergman, L. 2017. Vitamin D in Pain Management. International Journal of Molecular Sciences, 18(10):1–9.
Kroll, P. B. 2012. Intravenous ibuprofen for postoperative pain. Pain Management, 2(1):47–54.
Lyon, C., Claus, L. W., Jarrett, J. B., Stevermer, J. J. 2019. PURLs: Less is more when it comes to ketorolac for pain. The Journal of Family Practice, 68(1):41–42.
Nugent, C. C., Falkson, S. R., Terrell, J. M. 2018. H2 Blockers. StatPearls Publishing, Treasure Island (FL), 26 Sep 2018.
Pierik, J. G. J. 2015. Pain Management in the Emergency Chain: The Use and Effectiveness of Pain Management in Patients with Acute Musculoskeletal Pain. Pain Medicine (United States), 16(5):970– 984.
Samuel, S., Nguyen, T., Choi, H. A. 2017. Pharmacologic Characteristics of Corticosteroids. Journal of Neurocritical Care, 10(2):53–59.
Schug, S. A., Arshad, A. A. M. 2017. Acute and chronic musculoskeletal pain: Pharmacological management. Medicine Today, 18(1):14–20.
Shanechi, M., Eke, O., Gottlieb, M. 2018. Comparison of ketorolac dosing in an emergency department setting. Canadian Journal of Emergency Medicine, 20(S2):S74–S77.
WHO 2021. Musculoskeletal conditions. World Health Organization, Updated on: 8 February 2021.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.